|
CLTC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.267400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.285800E-01 |
| Normal-vs-Stage2 |
8.407200E-01 |
| Normal-vs-Stage3 |
6.882400E-02 |
| Normal-vs-Stage4 |
7.064400E-02 |
| Stage1-vs-Stage2 |
2.300800E-01 |
| Stage1-vs-Stage3 |
3.396600E-01 |
| Stage1-vs-Stage4 |
3.653400E-01 |
| Stage2-vs-Stage3 |
1.009180E-01 |
| Stage2-vs-Stage4 |
9.703900E-02 |
| Stage3-vs-Stage4 |
8.459600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.602590E-01 |
| Normal-vs-AfricanAmerican |
5.878800E-01 |
| Normal-vs-Asian |
7.642100E-02 |
| Caucasian-vs-AfricanAmerican |
1.233380E-01 |
| Caucasian-vs-Asian |
4.565000E-01 |
| AfricanAmerican-vs-Asian |
6.380500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.448000E-02 |
| Normal-vs-Female |
3.553800E-01 |
| Male-vs-Female |
1.770620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.216000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.146430E-01 |
| Normal-vs-Age(61-80Yrs) |
2.956400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.516600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.745000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.289800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.386200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.365400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.856200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.983800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.931200E-01 |
| Classical-VS-Follicular |
4.222400E-01 |
| Classical-VS-Other |
3.692200E-02 |
| Classical-VS-Normal |
4.597200E-01 |
| Tall-VS-Follicular |
8.871200E-01 |
| Tall-VS-Other |
6.154200E-02 |
| Tall-VS-Normal |
2.243600E-01 |
| Follicular-VS-Other |
1.154030E-01 |
| Follicular-VS-Normal |
2.205400E-01 |
| Other-VS-Normal |
9.898900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.447390E-01 |
| Normal-vs-N1 |
9.504700E-03 |
| N0-vs-N1 |
1.054850E-01 |
|
|
